Juan Carlos Martínez-Escoriza

Juan Carlos Martínez-Escoriza

Auto-generated profile, based on publicly available information

Juan Carlos Martínez-Escoriza

Department of Obstetrics and Gynecology, University General Hospital of Alicante, Alicante, Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CECecilia M. Egoavil
Cecilia M. Egoavil
CACristina Alenda
Cristina Alenda
ACAdela Castillejo
Adela Castillejo
APArtemio Paya
Artemio Paya
GPGloria Peiro
Gloria Peiro
JSJosé Luis Soto
José Luis Soto
Lynch syndrome (LS) is a hereditary condition that increases the risk for endometrial and other cancers. The identification of endometrial cancer (EC) patients with LS has the potential to influence life-saving interventions. We aimed to study the prevalence of LS among EC patients in our population. Universal screening for LS was applied for a consecutive series EC. Tumor testing using microsatellite instability (MSI), immunohistochemistry (IHC) for mismatch-repair (MMR) protein expression and MLH1-methylation analysis, when required, was used to select LS-suspicious cases. Sequencing of corresponding MMR genes was performed. One hundred and seventy-three EC (average age, 63 years) were screened. Sixty-one patients (35%) had abnormal IHC or MSI results. After MLH1 methylation analysis, 27 cases were considered suspicious of LS. From these, 22 were contacted and referred for genetic counseling. Nineteen pursued genetic testing and eight were diagnosed of LS. Mutations were more frequent in younger patients (<50 yrs). Three cases had either intact IHC or MSS and reinforce the need of implement the EC screening with both techniques. The prevalence of LS among EC patients was 4.6% (8/173); with a predictive frequency of 6.6% in the Spanish population. Universal screening of EC for LS is recommended.

13 August 2012 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
VSV Serra
V Serra
APA Perales
A Perales
JMJ Meseguer
J Meseguer
JPJj Parrilla
Jj Parrilla
CLC Lara
C Lara
APA Pellicer
A Pellicer
Objective  Previous trials have shown little benefit for preventing preterm birth in twin pregnancies using 90–200 mg of daily vaginal natural progesterone. Higher doses have not been tested. Our aim was to determine the efficacy and safety of two different daily doses of vaginal natural progesterone (200 and 400 mg), compared with placebo, for preventing preterm birth in unselected twin pregnancies.Design  Randomised controlled double‐blind multicentre trial (1:1:1).Setting  The study was carried out in five university centres from Valencia, Murcia and Alicante (Spain).Population  Women with dichorionic diamniotic twin pregnancies.Methods  The women self‐inserted two vaginal pessaries daily, containing placebo (n = 96), 200 mg of natural progesterone (n = 97) or 400 mg of natural progesterone (n = 97), from 20 to 34 weeks of gestation or delivery. Randomisation was performed by an external centre. Data were analysed on an intention‐to‐treat basis.Main outcome measure  Preterm birth rate.Results  The baseline characteristics for placebo and progesterone groups were similar. Comparison of the three groups and analysis of progesterone‐treated versus untreated women showed similar pregnancy and neonatal outcomes. The proportion of preterm and very preterm births, low birthweight, perinatal mortality and neonatal morbidity showed no differences between the three groups. Similar results were also obtained when comparing the 200‐ versus 400‐mg progesterone groups. No serious adverse effects were encountered.Conclusions  Vaginal progesterone therapy was generally well tolerated, but failed to prevent preterm births in unselected dichorionic diamniotic twin pregnancies. The 400‐mg progesterone dose offered no advantages over the 200‐mg regimen.

8 May 2017 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SGSILVIA DELGADO GARCÍA
SILVIA DELGADO GARCÍA
JMJuan-Carlos Martínez-Escoriza
Juan-Carlos Martínez-Escoriza
AAAlfonso Alba
Alfonso Alba
TMTina-Aurora Martín-Bayón
Tina-Aurora Martín-Bayón
HBHortensia Ballester-Galiana
Hortensia Ballester-Galiana
JPJose Ponce-Lorenzo
Jose Ponce-Lorenzo
Breast cancer is one of the most important neoplasia among women. It was recently suggested that biological agents could be the etiological cause, particularly Human Papilloma Virus (HPV). The aim of this study was to explore the presence of HPV DNA in a case-control study. We performed our study including 251 cases (breast cancer) and 186 controls (benign breast tumors), using three different molecular techniques with PCR (GP5/GP6, CLART® and DIRECT FLOW CHIP®). HPV DNA was evidenced in 51.8% of the cases and in 26.3% of the controls (p < 0.001). HPV-16 was the most prevalent serotype. The odds ratio (OR) of HPV within a multivariate model, taking into account age and breastfeeding, was 4.034. Our study, with methodological rigour and a sample size not previously found in the literature, demonstrate a significant presence of HPV DNA in breast cancer samples. A possible causal relationship, or mediation or not as a cofactor, remains to be established by future studies.

1 April 2014 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
JEJ.C. Martínez Escoriza
J.C. Martínez Escoriza
AMA.M. Palacios Marqués
A.M. Palacios Marqués
JFJ.A. López Fernández
J.A. López Fernández
ERE. Feliu Rey
E. Feliu Rey
PMP. Martín Medina
P. Martín Medina
CSC. Oliver Sánchez
C. Oliver Sánchez

28 January 2014 in BMJ Case Reports
Verified
Journal Article
Closed access
SGSILVIA DELGADO GARCÍA
SILVIA DELGADO GARCÍA
APAna Palacios-Marqués
Ana Palacios-Marqués
JMJuan Carlos Martínez-Escoriza
Juan Carlos Martínez-Escoriza
TMTina-Aurora Martín-Bayón
Tina-Aurora Martín-Bayón
Acute genital ulcers, also known as acute vulvar ulcers, ulcus vulvae acutum or Lipschütz ulcers, refer to an ulceration of the vulva or lower vagina of non-venereal origin that usually presents in young women, predominantly virgins. Although its incidence is unknown, it seems a rare entity, with few cases reported in the literature. Their aetiology and pathogenesis are still unknown. The disease is characterised by an acute onset of flu-like symptoms with single or multiple painful ulcers on the vulva. Diagnosis is mainly clinical, after exclusion of other causes of vulvar ulcers. The treatment is mainly symptomatic, with spontaneous resolution in 2 weeks and without recurrences in most cases. We present a case report of a 13-year-old girl with two episodes of acute ulcers that fit the clinical criteria for Lipschütz ulcers.

2 November 2012 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
APAna Palacios
Ana Palacios
MVMónica De Vera
Mónica De Vera
JMJuan Carlos Martínez‐Escoriza
Juan Carlos Martínez‐Escoriza